| 21/04/26 | 07:00:07 | 21 Apr 2026 | | Completion Share Exchange Agreement Issue Equity |
| 13/04/26 | 14:58:05 | 13 Apr 2026 | | Update on Share Exchange Agreement with Kira |
| 01/04/26 | 07:00:07 | 1 Apr 2026 | | Update on Share Exchange Agreement with Kira |
| 16/03/26 | 07:00:13 | 16 Mar 2026 | | Conditional Share Exchange Agreement |
| 31/12/25 | 12:21:26 | 31 Dec 2025 | | Result of Annual General Meeting |
| 29/12/25 | 07:00:06 | 29 Dec 2025 | | Interim Results |
| 08/12/25 | 15:00:01 | 8 Dec 2025 | | Notice of Annual General Meeting |
| 24/10/25 | 07:00:12 | 24 Oct 2025 | | Restatement of Financial Statements |
| 30/09/25 | 17:51:18 | 30 Sept 2025 | | Annual Results to 31 March 2025 |
| 29/08/25 | 17:37:39 | 29 Aug 2025 | | Director's Dealings |
| 29/08/25 | 10:55:59 | 29 Aug 2025 | | Board Appointment of (Lord) James Nicholas Bethell |
| 24/07/25 | 16:45:09 | 24 Jul 2025 | | Details of Advanced Subscription & Company Update |
| 24/07/25 | 07:00:11 | 24 Jul 2025 | | £150,000 Advanced Subscription Agreement |
| 02/07/25 | 07:00:06 | 2 Jul 2025 | | Appointment of corporate broker |
| 05/06/25 | 12:40:16 | 5 Jun 2025 | | Formation of UAE joint venture company |
| 03/06/25 | 16:23:12 | 3 Jun 2025 | | TR-1: Notification of major holdings |
| 22/05/25 | 07:00:09 | 22 May 2025 | | £650,000 Placing at 17.3p per share |
| 01/04/25 | 07:00:12 | 1 Apr 2025 | | Update on JV including £20m Funding |
| 28/02/25 | 07:00:10 | 28 Feb 2025 | | Director’s Dealings |
| 10/02/25 | 07:00:09 | 10 Feb 2025 | | £20M MoU for Funding Clinical Development in UAE |
| 31/01/25 | 07:00:06 | 31 Jan 2025 | | Admission on AQSE and First Day of Dealings |
